PFE — PFIZER INC
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 78003 ·
Last close
$28.72
Market Cap
$163.69B
52W High
$29.21
52W Low
$22.09
ADV30
33,630,299
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 15,034,000,000 | 10,942,000,000 | 3,537,000,000 | -248,000,000 | 201,131,000,000 | 976,000,000 | 115,639,000,000 |
| Mar 2026 | 14,450,000,000 | 10,902,000,000 | 4,131,000,000 | 2,687,000,000 | 207,618,000,000 | 1,703,000,000 | 117,214,000,000 |
| Dec 2025 | 17,557,000,000 | 12,285,000,000 | 3,475,000,000 | -1,648,000,000 | 208,160,000,000 | 1,142,000,000 | 121,385,000,000 |
| Sep 2025 | 16,654,000,000 | 12,482,000,000 | 4,137,000,000 | 3,541,000,000 | 208,731,000,000 | 1,343,000,000 | 115,635,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$13,403,000,000
Investing CF
$-5,683,000,000
Financing CF
$-8,399,000,000
CapEx
$-2,416,000,000
Dividends Paid
$-9,785,000,000
Buybacks
—
EPS Diluted TTM
$0.76
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$112,087,000,000
Inventory
$9,945,000,000
Receivables
$16,192,000,000
ST Investments
$10,722,000,000
EBIT TTM
$6,907,000,000
Pretax Income TTM
$4,209,000,000
Interest Exp TTM
$2,698,000,000
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$63,695,998,976
EBITDA
$25,383,000,064
Free Cash Flow
$12,485,624,832
Enterprise Value
$210,072,944,640
Total Cash
$11,704,000,512
Total Debt
$63,480,000,512
Shares Out
5,699,673,589
Trailing EPS
$0.76
Book Value
$14.95
ROE
5.0%
ROA
5.8%
Div Yield
6.20%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 62,579,000,000 | 17,407,000,000 | 7,771,000,000 | 208,160,000,000 | 121,385,000,000 | 86,476,000,000 | 11,704,000,000 |
| Dec 2024 | 63,627,000,000 | 14,938,000,000 | 8,031,000,000 | 213,396,000,000 | 124,899,000,000 | 88,203,000,000 | 12,744,000,000 |
| Dec 2023 | 59,554,000,000 | 4,417,000,000 | 2,119,000,000 | 226,501,000,000 | 137,213,000,000 | 89,014,000,000 | 8,700,000,000 |
| Dec 2022 | 101,175,000,000 | 38,117,000,000 | 31,372,000,000 | 197,205,000,000 | 101,289,000,000 | 95,661,000,000 | 29,267,000,000 |
TTM Snapshot
Revenues TTM
$67,546,000,000
NetIncome TTM
$13,658,000,000
OpCashFlow TTM
$0
Assets (Latest)
$208,160,000,000
Forward EPS
$2.90
Max Pain — expiry 2026-10-02
max pain strike: $28.00 · spot: $28.72 · call oi: 35,230 · put oi: 12,814
Expected Move to 2026-10-02:
±$0.64
(2.21%) —
implied range
$28.08 –
$29.35
· ATM straddle on $28.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | $174.73B | $100.98 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $133.74B | $527.67 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $130.49B | $63.88 | — |
| NVO | NOVO NORDISK A S | $129.45B | $38.71 | — |
| NONOF | NOVO NORDISK A S | $129.28B | $38.66 | — |
News headlines (Yahoo Finance, 1h cache)
Pfizer (PFE) Heads To ESMO With 45 Oncology Abstracts And Fresh Cancer Data
2026-09-28 14:09 · Yahoo
BioNTech to Close Manufacturing Sites in Germany and Singapore After Sale Process Ends
2026-09-28 14:06 · Yahoo
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
2026-09-28 12:00 · Yahoo
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
2026-09-28 10:45 · Yahoo
Global Cyclic Peptide Library Market Outlook and Forecast, 2026-2032 - AI-Enabled Discovery Fuels 16.32% CAGR Toward USD 9.86 Billion as PeptiDream, Bicycle Therapeutics, Pfizer and Roche Advance Comp
2026-09-28 09:07 · Yahoo
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?
2026-09-27 23:09 · Yahoo
Pfizer vs. Medtronic: Which Healthcare Turnaround is More Convincing?
2026-09-27 22:57 · Yahoo
Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?
2026-09-27 22:51 · Yahoo
Pfizer (PFE) Balances Global Pricing Opportunity with New Revenue Sharing
2026-09-27 20:27 · Yahoo
Pfizer (PFE) Targets Air Traffic Fees Over Unpaid Vaccines. Can it Turn a Court Win Into Cash?
2026-09-26 03:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.